http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9418958-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40c5bed028a47879ddc2d20c75bab72e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1631fcb650b00a4412eaaa37ea488db9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
filingDate 1993-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b798b641047bba37e0a5d5a79ebb4ee7
publicationDate 1994-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9418958-A1
titleOfInvention 5-ht2 receptor antagonist compositions useful in treating venous conditions
abstract Treatment of compositions containing 5-HT2 receptor antagonists useful in treating such venous conditions as hemorrhoids, varicose veins, venous insufficiency and wounds. In particular it comprises use of a 5-hydroxytryptamine-2 receptor antagonist (5-HT2) at an effective therapeutic dose to treat a human or animal suffering from such a condition. The 5-HT2 receptor antagonist can also be administered prophylactically.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-750603-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9838165-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5605902-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012026914-A1
priorityDate 1992-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4064254-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0526434-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4411901-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4487773-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID55751
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163647990
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228562112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232350580
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66584305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232350576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226493708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465280487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69852117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429104
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17897428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16219847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234708569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67818435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234707962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67818049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66760136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID247704
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6426689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18545186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226956827

Total number of triples: 79.